Specialty Area
Spotlight
Topics
Institute for Value-Based Medicine
About AJMC
Podcasts
CE
Subscribe
- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Use of Xanomeline/Trospium in Clinical Practice
Panelists discuss how integrating xanomeline/trospium into clinical practice may expand safe and effective treatment options.
EP: 1.Clinical and Economic Burden of Schizophrenia
EP: 2.Symptoms Associated with Schizophrenia
EP: 3.Risk Factors for Schizophrenia
EP: 4.Challenges of Early and Accurate Diagnosis in Schizophrenia
EP: 5.Exploring Schizophrenia Progression and Its Impact on Quality of Life
EP: 6.Consequences of Relapse in Schizophrenia Care
EP: 7.“Addressing Social Determinants of Health and Unmet Needs in Schizophrenia”
EP: 8.Current Treatment Guidelines for Schizophrenia
EP: 9.First- and Second-Generation Antipsychotic Therapies and Treatment Sequencing
EP: 10.Switching Therapies, Managing Adverse Effects, and Adherence Challenges
EP: 11.Xanomeline/Trospium Mechanism of Action, Efficacy, and Safety
Now Viewing
EP: 12.Use of Xanomeline/Trospium in Clinical Practice
Panelists discuss how clinicians are beginning to integrate xanomeline/trospium into practice for patients who have struggled with traditional therapies. They share early observations of improved engagement and cognitive clarity.
Panelists discuss how appropriate patient selection, titration, and adverse effect monitoring are key to maximizing outcomes.
Panelists discuss how broad adoption depends on payer coverage and growing real-world data validating long-term safety and effectiveness.
Related Videos
Related Content
